Mapping, genomic organization and promoter analysis of the human prostate-specific membrane antigen gene

Biochimica et Biophysica Acta - Gene Structure and Expression

Volumn 1443, Issue 1-2, 1998, Pages 113-127

  O'Keefe, Denise S ^a   Su, Sai L ^a,f   Bacich, Dean J ^a   Horiguchi, Yutaka ^a   Luo, Ying ^a   Powell, C Thomas ^a   Zandvliet, Dorothea ^b   Russell, Pamela J ^c   Molloy, Peter L ^b   Nowak, Norma J ^d   Shows, Thomas B ^d   Mullins, Cami ^e   Vonder Haar, Raymond A ^e   Fair, William R ^a   Heston, Warren D W ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b CSIRO   (Australia)

^c PRINCE OF WALES HOSPITAL   (Australia)

^d ROSWELL PARK CANCER INSTITUTE   (United States)

^e Lark Technologies Inc   (United States)

^f LLC   (United States)

Author keywords

Gene duplication; Promoter; Prostate cancer; Prostate specific membrane antigen; PSM

Indexed keywords

GAMMA GLUTAMYL HYDROLASE; N ACETYLASPARTYLGLUTAMIC ACID; PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CHROMOSOME 11Q; GENE DUPLICATION; GENE MAPPING; GENETIC ANALYSIS; GENETIC ORGANIZATION; HUMAN; HUMAN TISSUE; MALE; NEUROLOGIC DISEASE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER;

ANTIGENS, SURFACE; BACTERIOPHAGE P1; BASE SEQUENCE; CARBOXYPEPTIDASES; CELL LINE; CHROMOSOME MAPPING; CLONING, MOLECULAR; CODON, INITIATOR; GENE DUPLICATION; GLUTAMATE CARBOXYPEPTIDASE II; HUMANS; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS);

EID: 0032570030     PISSN: 01674781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-4781(98)00200-0     Document Type: Article

References (55)

1. Landis S.H., Murray T., Bolden S., Wingo P.A. Cancer Statistics, 1998. Ca Cancer J. Clin. 48:1998;6-29.
2. Israeli R.S., Powell C.T., Corr J.G., Fair W.R., Heston W.D.W. Expression of the prostate-specific membrane antigen. Cancer Res. 54:1994;1807-1811.
3. Tjoa B.A., Erickson S.J., Bowes V.A., Ragde H., Kenny G.M., Cobb O.E., Ireton R.C., Troychak M.J., Boynton A.L., Murphy G.P. Follow-up evaluation of prostate cancer patients infused with autologous dendritic cells pulsed with PSMA peptides. Prostate. 32:1997;272-278.
4. Pinto J.T., Suffoletto B.P., Berzin T.M., Qia C.H., Lin S., Tong W.P., May F., Mukherjee B., Heston W.D.W. Prostate-specific membrane antigen: a novel folate hydrolase in human prostatic carcinoma cells. Clin. Cancer Res. 2:1996;1445-1451.
5. Carter R.E., Feldman A.R., Coyle J.T. Prostate-specific membrane antigen is a hydrolase with substrate and pharmacologic characteristics of a neuropeptidase. Proc. Natl. Acad. Sci. USA. 93:1996;749-753.
6. Silver D.A., Pellicer I., Fair W.R., Heston W.D.W., Cordon-Cardo C. Prostate-specific membrane antigen expression in normal and malignant human tissues. Clin. Cancer Res. 3:1997;81-85.
7. Kawakami M., Nakayama J. Enhanced expression of prostate-specific membrane antigen gene in prostate cancer as revealed by in situ hybridization. Cancer Res. 57:1997;2321-2324.
8. Liu H., Moy P., Kim S., Xia Y., Rajasekaran A., Navarro V., Knudsen B., Bander N.H. Monoclonal antibodies to the extracellular domain of prostate-specific membrane antigen also react with tumor vascular endothelium. Cancer Res. 57:1997;3629-3634.
9. 111indium-labeled monoclonal antibody CYT-356. J. Urol. 152:1994;1952-1955.
10. 111indium labeled CYT-356 for the detection of occult prostate cancer recurrence. J. Urol. 152:1994;1490-1495.
11. Wright G.L. Jr., Haley C., Beckett M.L., Schellhammer P.F. Expression of prostate-specific membrane antigen in normal, benign and malignant prostate tissues. Urol. Oncol. 1:1995;18-28.
12. Horoszewicz J.S., Kawinski E., Murphy G.P. Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients. Anticancer Res. 7:1987;927-936.
13. Israeli R.S., Miller W.H. Jr., Su S.L., Powell C.T., Fair W.R., Samadi D.S., Huryk R.F., DeBlasio A., Edwards E.T., Wise G.J., Heston W.D.W. Sensitive nested reverse transcription polymerase chain reaction detection of circulating prostatic tumor cells: comparison of prostate-specific membrane antigen and prostate-specific antigen-based assays. Cancer Res. 54:1994;6306-6310.
14. Rinker-Schaeffer C.W., Hawkins A.L., Su S.L., Israeli R.S., Griffin C.A., Isaacs J.T., Heston W.D.W. Localization and physical mapping of the prostate-specific membrane antigen (PSM) gene to human chromosome 11. Genomics. 30:1995;105-108.
15. Leek J., Lench N., Maraj B., Bailey A., Carr I.M., Andersen S., Cross J., Whelan P., MacLennan K.A., Meredith D.M., Markham A.F. Prostate-specific membrane antigen: evidence for the existence of a second related human gene. Br. J. Cancer. 72:1995;583-588.
16. Giebel L.B., Strunk K.M., Spritz R.A. Organization and nucleotide sequences of the human tyrosinase gene and a truncated tyrosinase-related segment. Genomics. 9:1991;435-445.
17. Qin S., Nowak N.J., Zhang J., Sait S.N., Mayers P.G., Higgins M.J., Cheng Y., Li L., Munroe D., Gerhard D.S., Weber B.H., Bric E., Housman D.E., Evans G.A., Shows T.B. A high-resolution physical map of human chromosome 11. Proc. Natl. Acad. Sci. USA. 93:1996;3149-3154.
18. Perlin M.W., Duggan D.J., Davis K., Farr J.E., Findler R.B., Higgins M.J., Nowak N.J., Evans G.A., Qin S., Zhang J., Shows T.B., James M.R., Richard C.W. III. Rapid construction of integrated maps using inner product mapping: YAC coverage of human chromosome 11. Genomics. 28:1995;315-327.
19. Israeli R.S., Powell C.T., Fair W.R., Heston W.D.W. Molecular cloning of a complementary DNA encoding a prostate-specific membrane antigen. Cancer Res. 53:1993;227-230.
20. Shapiro M.B., Senapathy P. RNA splice junctions of different classes of eukaryotes: sequence statistics and functional implications in gene expression. Nucleic Acids Res. 15:1987;7155-7174.
21. Su S.L., Huang I.P., Fair W.R., Powell C.T., Heston W.D.W. Alternatively spliced variants of prostate-specific membrane antigen RNA: ratio of expression as a potential measurement of progression. Cancer Res. 55:1995;1441-1443.
22. Gardiner-Garden M., Frommer M. CpG islands in vertebrate genomes. J. Mol. Biol. 196:1987;261-282.
23. Gardiner-Garden M., Frommer M. Transcripts and CpG islands associated with the pro-opiomelanocortin gene and other neurally expressed genes. J. Mol. Endocrinol. 12:1994;365-382.
24. Antequera F., Bird A. Number of CpG islands and genes in human and mouse. Proc. Natl. Acad. Sci. USA. 90:1995;11995-11999.
25. Troyer J.K., Feng Q., Beckett M.L., Wright G.L. Jr. Biochemical characterization and mapping of the 7E11-C5.3 epitope of the prostate-specific membrane antigen. Urol. Oncol. 1:1995;29-37.
26. Schellhammer P.F., Kuban D.A., el-Mahdi A.M. Local failure after definitive radiation or surgical therapy for carcinoma of the prostate and options for prevention and therapy. Urol. Clin. North Am. 18:1991;495.
27. Troyer J.K., Beckett M.L., Wright G.L. Jr. Location of prostate-specific membrane antigen in the LNCaP prostate carcinoma cell line. Prostate. 30:1997;232-242.
28. W.D.W. Heston, Biologic implications for prostatic function following identification of prostate-specific membrane antigen as a novel folate hydrolase/neurocarboxypeptidase, in: R.K. Naz (Ed.), Prostate: Basic and Clinical Aspects, CRC Press, Boca Raton, FL, 1997, pp. 267-298.
29. Rawlings N.D., Barrett A.J. Structure of membrane glutamate carboxypeptidase. Biochim. Biophys. Acta. 1339:1997;247-252.
30. Shneider B.L., Thevananther S., Moyer M.S., Walters H.C., Rinaldo P., Devarajan P., Sun A.Q., Dawson P.A., Ananthanarayanan M. Cloning and characterization of a novel peptidase from rat and human ileum. J. Biol. Chem. 272:1997;31006-31015.
31. S.T. Smale, in: Conaway and Conaway (Eds.), Transcription: Mechanisms and Regulation, Raven Press, New York, 1994, pp. 63-81.
32. Javahery R., Khachi A., Lo K., Zenzie-Gregory B., Smale S.T. DNA sequence requirements for transcriptional initiator activity in mammalian cells. Mol. Cell. Biol. 14:1994;116-127.
33. Steger D.J., Hecht J.H., Mellon P.L. GATA-binding proteins regulated the human gonadotropin alpha-subunit gene in the placenta and pituitary gland. Mol. Cell. Biol. 14:1994;5592-5602.
34. Rivas C.I., Vera J.C., Delgado-Lopez F., Heaney M.L., Guaiquil V.H., Zhang R.H., Scher H.I., Concha I.I., Nualart F., Cordon-Cardo C., Golde D.W. Expression of granulocyte-macrophage colony-stimulating factor receptors in human prostate cancer. Blood. 91:1998;1037-1043.
35. Roy A.K., Chatterjee B. Androgen action. Crit. Rev. Eukaryot. Gene Expr. 5:1995;157-176.
36. Koop B.F., Tagle D.A., Goodman M., Slightom J.L. A molecular view of primate phylogeny and important systematic and evolutionary questions. Mol. Biol. Evol. 6:1989;580-612.
37. Zischler H., Geisert H., von Haeseler A., Paabo S. A nuclear 'fossil' of the mitochondrial D-loop and the origin of modern humans. Nature. 378:1995;489-492.
38. Perna N.T., Kocher T.D. Mitochondrial DNA: molecular fossils in the nucleus. Curr. Biol. 6:1996;128-129.
39. Kozak M. Recognition of AUG and alternative initiator codons is augmented by G in position +4 but is not generally affected by the nucleotides in positions +5 and +6. EMBO J. 16:1997;2482-2492.
40. Bzdega T., Turi T., Wroblewska B., She D., Chung H.S., Kim H., Neale J.H. Molecular cloning of a peptidase against N-acetylaspartylglutamate from a rat hippocampal cDNA library. J. Neurochem. 69:1997;2270-2277.
41. McClelland A., Kuhn L.C., Ruddle F.H. The human transferrin receptor gene: genomic organization, and the complete primary structure of the receptor deduced from a cDNA sequence. Cell. 39:1984;267-274.
42. Evans P., Kemp J. Exon/intron structure of the human transferrin receptor gene. Gene. 199:1997;123-131.
43. Denekamp J. Angiogenesis, neovascular proliferation and vascular pathophysiology as targets for cancer therapy. Br. J. Radiol. 66:1993;181-196.
44. Arap W., Pasqualini R., Ruoslahti E. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science. 279:1998;377-380.
45. Sinclair A.H., Berta P., Palmer M.S., Hawkins J.R., Griffiths B.L., Smith M.J., Foster J.W., Frischauf A.M., Lovell-Badge R., Goodfellow P.N. A gene from the human sex-determining region encodes a protein with homology to a conserved DNA-binding motif. Nature. 346:1990;240-244.
46. Berta P., Hawkins J.R., Sinclair A.H., Taylor A., Griffiths B.L., Goodfellow P.N., Fellous M. Genetic evidence equating SRY and the testis-determining factor. Nature. 348:1990;448-450.
47. Pontiggia A., Rimini R., Harley V.R., Goodfellow P.N., Lovell-Badge R., Bianchi M.E. Sex-reversing mutations affect the architecture of SRY-DNA complexes. EMBO J. 13:1994;6115-6124.
48. Tricoli J.V., Yao J.L., D'Souza S.A., Bracken R.B. Detection of sex-region Y (SRY) transcripts in human prostate adenocarcinoma and benign prostatic hypertrophy. Genes Chromosomes Cancer. 8:1993;28-33.
49. Benbrook D.M., Jones N.C. Different binding specificities and transactivation of variant CRE's by CREB complexes. Nucleic Acids Res. 22:1994;1463-1469.
50. Murtha P.E., Zhu W., Zhang J., Zhang S., Young C.Y. Effects of Ca++ mobilization on expression of androgen-regulated genes: interference with androgen receptor-mediated transactivation by AP-I proteins. Prostate. 33:1997;264-270.
51. Zorick T.S., Lemke G. Schwann cell differentiation. Curr. Opin. Cell Biol. 8:1996;870-876.
52. Thiesen H.J., Bach C. Target detection assay (TDA): a versatile procedure to determine DNA binding sites as demonstrated on SP1 protein. Nucleic Acids Res. 18:1990;3203-3209.
53. P.F. Johnson, S.C. Williams, CCAAT/enhancer binding (C/EBP) proteins, in: F. Tronche and M. Yaniv (Eds.), Liver Gene Expression (Molecular Biology Intelligence Unit), R.G. Landes, Austin, TX, 1994, pp. 231-258.
54. Shrivastava A., Calame K. An analysis of genes regulated by the multi-functional transcriptional regulator Yin Yang-1. Nucleic Acids Res. 22:1994;5151-5155.
55. He X., Gerrero R., Simmons D.M., Park R.E., Lin C.R., Swanson L.W., Rosenfeld M.G. Tst-1, a member of the POU domain gene family, binds the promoter of the gene encoding the cell surface adhesion molecule Po. Mol. Cell. Biol. 11:1991;1739-1744.